Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Acridinium C2 NHS Ester (AC205)
Cat.#: ASSD-205
Specifications
Description Acridinium C2 NHS Ester is a chemical compound that can be used to mark proteins and nucleic acids. It will emit light in the presence of hydrogen peroxide when it is attached to proteins and nucleic acids through covalent bonding, Synonyms Acridinium C2 N-hydroxysuccinimide ester; 4-(2-Succinimidyl-oxycarbonylethyl)-phenyl-10-acridinium-9-carboxylate Triflurormethyl Sulfonate Size 5 mg, 10 mg Applications Chemiluminescent labeling reagent Molecule Weight 632.56 Molecular formula C28H23N2O6•CF3O3S CAS Number 177332-37-5 MDL Number MFCD00797661 Solubility Soluble in DMSO (~25 mg/ml), methanol, DMF (~25 mg/ml), and 1:1 solution of DMSO: PBS (pH 7.2) (~1 1 mg/ml). Insoluble in water. Storage Store at -20° C Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-111 Propidium Iodide (AC111) 10 mg, 50 mg inquiry ASSD-104 Hoechst 33258 (AC104) 25 mg, 100 mg inquiry ASSD-177 Fluorescein 5-Maleimide (AC177) 25 mg inquiry ASSD-159 Erythrosin B (AC159) 1g, 5g inquiry ASSD-178 5-(Iodoacetamido)fluorescein (AC178) 25 mg, 100 mg, 250 mg inquiry ASSD-135 JC-1 (AC135) 5 mg inquiry ASSD-152 Biocytin (AC152) 10 mg, 50 mg inquiry ASSD-209 Tetramethylrhodamine isothiocyanate Isomer R (AC209) 5 mg, 10 mg inquiry ASSD-173 FITC-Dextran 70 (AC173) 100 mg, 500 mg inquiry ASSD-224 Antifade Fluorescence Mounting Medium with DAPI (aqueous) (AC224) 10 mL inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket